Tourmaline Bio Inc. Cash Flow-to-Debt Ratio
Tourmaline Bio Inc. cash flow-to-debt ratio. Tourmaline Bio Inc. (TRML) has a Cash Flow-to-Debt Ratio of -2.01x as of June 2025, meaning its operating cash flow of $-20.26 Million could theoretically repay -2% of its total liabilities ($10.10 Million) in one year. Check TRML cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Tourmaline Bio Inc. (2019–2024)
Cash flow-to-debt ratio of Tourmaline Bio Inc. from 2019 to 2024. Historical debt coverage capacity for Tourmaline Bio Inc. across 6 annual periods. Check how aggressively does Tourmaline Bio Inc. reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Tourmaline Bio Inc. Cash Flow-to-Debt Ratio by Year (2019–2024)
Tourmaline Bio Inc. cash flow-to-debt ratio by year from 2019 to 2024. Year-by-year debt coverage analysis for Tourmaline Bio Inc.. For the full cash flow conversion analysis, see TRML cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -8.63x | $-77.26 Million | $8.95 Million | ▼ -61.5% |
| 2023 | -5.35x | $-28.08 Million | $5.25 Million | ▼ -2286.4% |
| 2022 | -0.22x | $-6.46 Million | $28.83 Million | ▲ +95.2% |
| 2021 | -4.64x | $-39.99 Million | $8.61 Million | ▼ -15.3% |
| 2020 | -4.03x | $-19.21 Million | $4.77 Million | ▲ +46.3% |
| 2019 | -7.50x | $-17.66 Million | $2.35 Million | — |